Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T17:49:15.341Z Has data issue: false hasContentIssue false
  • English
  • Français

Passive protection of mice against infection with Trypanosoma cruzi with plasma: the use of blood- and vector bug-derived trypomastigote challenge

Published online by Cambridge University Press:  06 April 2009

N. McHardy
N. McHardy
Affiliation:
The Wellcome Research Laboratories, Department of Parasitology, Beckenham, Kent
Get access Rights & Permissions [Opens in a new window]

Summary

A study was made of the protective effects of plasma (CMP) from mice convalescent from infection with Trypanosoma cruzi. A single dose of CMP was injected into mice infected with blood trypomastigotes of 1 of each of 5 strains of T. cruzi. Protection was greatest with strains BG, M1 and Y, and least with strain Peru. Strain Tulahuen was of intermediate susceptibility. The protective effect of CMP was found to be similar in mice infected by metacyclic trypomastigotes harvested from vector bugs and mice infected by blood trypomastigotes. Plasma (IMP) from mice hyperimmunized with 6 doses of a killed T. cruzi epimastigote vaccine with saponin as an adjuvant gave no protection against challenge with strain Y, although a group of mice hyperimmunized in parallel with those from which IMP was taken were strongly resistant to challenge.

Type
Research Article
Information
Parasitology , Volume 80 , Issue 3 , June 1980 , pp. 471 - 478
Copyright
Copyright © Cambridge University Press 1980

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andrade, S. G. (1974). Caracterizacao de cepas do Trypanosoma cruzi isoladas no reconcavo baiano. Revista Patologia Tropical 3, 65–121.Google Scholar
Boné, J. G. & Parent, G. (1963). Stearic acid, an essential growth factor for Trypanosoma cruzi. Journal of General Microbiology 31, 261–6.CrossRefGoogle ScholarPubMed
Hauschka, T. S., Goodwin, M. B., Palmquist, J. & Brown, E. (1950). Immunological relationship between seven strains of Trypanosoma cruzi and its application in the diagnosis of Chagas' disease. American Journal of Tropical Medicine 30, 1–16.Google ScholarPubMed
Kagan, I. G. & Norman, L. (1961). Immunological studies on Trypanosoma cruzi. III. Duration of acquired immunity in mice initially infected with a North American strain of T. cruzi. Journal of Infectious Diseases 108, 213–17.CrossRefGoogle ScholarPubMed
Krettli, A. U. & Brener, Z. (1976). Protective effects of specific antibodies in Trypanosoma cruzi infections. Journal of Immunology 116, 755–60.CrossRefGoogle ScholarPubMed
McHardy, N. (1977 a). Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum. Tropenmedizin und Parasitologie 28, 195–201.Google ScholarPubMed
McHardy, N. (1977 b). Immunization of mice against Trypanosoma cruzi. The effect of size of dose, and route of injection, of immunizing and challenge inocula. Tropenmedizin und Parasitologie 28, 11–16.Google ScholarPubMed
McHardy, N. & Elphick, J. P. (1978). Immunization of mice against infection with Trypanosoma cruzi. Cross-immunization between five strains of the parasite using freeze-thawed vaccines containing epimastigotes of up to five strains. International Journal for Parasitology 8, 25–31.CrossRefGoogle ScholarPubMed
Neal, R. A. & McHardy, N. (1977). Comparison of infectivity of Trypanosoma cruzi blood stream trypomastigotes and metacyclic trypomastigotes from Rhodnius prolixus. Acta Tropica 34, 79–85.Google ScholarPubMed